SPY435.79-6.85 -1.55%
DIA344.82-3.79 -1.09%
IXIC14,650.99-318.98 -2.13%

Immutep Completes Patient Enrollment in Stage 2 of Part B of NSCLC Study; Shares Drop Early

MT Newswires · 09/01/2021 06:01

Please log in to view news